Van ECK Associates Corp Sells 2,413 Shares of McKesson Corporation $MCK

Van ECK Associates Corp decreased its holdings in McKesson Corporation (NYSE:MCK) by 4.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,156 shares of the company’s stock after selling 2,413 shares during the period. Van ECK Associates Corp’s holdings in McKesson were worth $40,293,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Norges Bank acquired a new position in shares of McKesson during the 2nd quarter valued at $1,346,661,000. Alliancebernstein L.P. increased its stake in shares of McKesson by 150.4% in the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock worth $1,661,956,000 after buying an additional 1,362,386 shares during the period. Arrowstreet Capital Limited Partnership raised its position in shares of McKesson by 56.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock worth $906,109,000 after acquiring an additional 446,060 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its stake in shares of McKesson by 45.6% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock worth $610,977,000 after buying an additional 261,296 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of McKesson by 2.0% during the 2nd quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company’s stock valued at $8,846,186,000 after purchasing an additional 232,286 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 over the last ninety days. 0.08% of the stock is owned by corporate insiders.

McKesson Price Performance

Shares of NYSE MCK opened at $934.13 on Thursday. The company’s 50 day simple moving average is $889.07 and its 200 day simple moving average is $821.67. McKesson Corporation has a fifty-two week low of $635.00 and a fifty-two week high of $999.00. The firm has a market capitalization of $114.42 billion, a P/E ratio of 26.87, a P/E/G ratio of 1.49 and a beta of 0.38.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts expect that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Wall Street Analysts Forecast Growth

MCK has been the topic of a number of analyst reports. Wells Fargo & Company upped their target price on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Robert W. Baird set a $968.00 target price on shares of McKesson in a report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Barclays boosted their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 18th. Finally, Raymond James Financial set a $970.00 target price on McKesson in a research report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.